Mahmoud Mahmoudian

Title: Mahmoud Mahmoudian: Innovator in Enzymatic Deracemization

Introduction

Mahmoud Mahmoudian is a distinguished inventor based in London, GB. He has made significant contributions to the field of enzymatic treatment, particularly in the deracemization of chiral amines. With a total of 4 patents to his name, Mahmoudian's work has garnered attention for its innovative approaches and practical applications.

Latest Patents

One of Mahmoudian's latest patents focuses on the deracemization of amines. This invention relates to a method for the chiral inversion of chiral amines through enzymatic treatment. The method employs a stereoselective enzymatic conversion alongside either a non-selective or partially selective chemical or enzymatic conversion, which can occur simultaneously or sequentially. Additionally, the invention outlines a method for selecting a suitable enzyme, particularly an amine oxidase, and for generating novel enzymes that are suitable for use in the deracemization process.

Career Highlights

Throughout his career, Mahmoudian has worked with notable companies such as Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in the field of enzymatic processes and innovation.

Collaborations

Mahmoudian has collaborated with several professionals in his field, including Michael John Dawson and Marina Victorovna Alexeeva. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Mahmoud Mahmoudian stands out as a prominent inventor in the realm of enzymatic deracemization. His innovative methods and collaborations have significantly impacted the field, showcasing his dedication to advancing scientific knowledge and practical applications.